Articles of the Month
Videos
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Articles
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma
Alvarado-Vazquez, P.A., Cardenas, E.I., Das, A. and Hallgren, J. Allergy. First published: 27 November 2022
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
Logan, K., Bahnson, H.T., Ylescupidez, A., et al. Allergy. First published: 27 November 2022
Prepregnancy body mass index and risk of childhood asthma
Rosenquist, N.A., Richards, M., Ferber, J.R., et al. Allergy. First published: 27 November 2022
Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice
Musiol, S., Harris, C.P., Karlina, R., et al. Allergy. First published: 24 November 2022
Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients
Spekhorst, L.S., van de Rijst, L.P., de Graaf, M., et al. Allergy. First published: 24 November 2022
Fenebrutinib and BTK inhibition: unveiling a new target for the treatment of chronic spontaneous urticaria
Carvallo, A., Sánchez-Fernández, S. and Morales-Palacios, M.P. Allergy. First published: 24 November 2022
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
Bet v 1-independent sensitization to major allergens in Fagales pollen: evidence at the T cell level
Polak, D., Vollmann, U., Grilo, J., et al. Allergy. First published: 24 November 2022
Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling
Bitting, K., Hedgespeth, B., Ehrhardt-Humbert, L.C., et al. Allergy. First published: 24 November 2022
GALTectomy increases the risk of allergic rhinitis: A nationwide population-based cohort study
Lin, T.-M., Hsu, H.-C., Shen, Y.-C., et al. Allergy. First published: 22 November 2022
Nutritional metabolites as biomarker for food intake to improve dietary-based randomized control trials
Venter, C. and Frei, R. Allergy. First published: 22 November 2022
Pest sensitization to cockroach, mouse, and rat: an Italian multicenter study
Liccardi, G., Maria Beatrice, B., Calzetta, L., et al. Allergy. First published: 18 November 2022
Frequent presence of major dust mite allergens in human digestive tissues of children with gastritis
Zhou, Y., Yang, S., Lin, Q., He, Q. and Cui, Y. Allergy. First published: 18 November 2022
RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity
Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes KITD816V in blood of mastocytosis and MCAS
Navarro-Navarro, P., Alvarez-Twose, I., Pérez-Pons, A., et al. Allergy. First published: 16 November 2022
Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022
Precision cut intestinal slices, a novel model of acute food allergic reactions
Hung, L., Celik, A., Yin, X., et al. Allergy. First published: 14 November 2022
Legends of Allergy and Immunology: Alberto Mantovani, a visionary scientist unraveling the complexity of innate immunity in cancer and inflammation
Moretta, L. and Sozzani, S. Allergy. First published: 13 November 2022
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: a systematic review
Broderick, C., Ziehfreund, S., van Bart, K., et al. Allergy. First published: 10 November 2022
Fracture incidence in children after developing atopic dermatitis: A Korean nationwide birth cohort study
Lee, S.W., Shin, Y.H., Shin, J.I., et al. Allergy. First published: 09 November 2022
Comprehensive analysis of human IL-4 receptor subunits shows compartmentalization in steady state and dupilumab treatment
Heeb, LEM, Boyman, O. Allergy. First published: 05 November 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
Sousa-Pinto, B, Schünemann, HJ, Sá-Sousa, A, et al. Allergy. First published: 03 November 2022
FcRn-targeting and ROS-responsive Fedratinib-incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis
Sun, W., Song, S., Li, G., et al. Allergy. First published: 03 November 2022
Prenatal diet, plasma micronutrients/metabolome and inflammatory status influence the development of atopic eczema in early childhood
Ta, L.D.H., Chan, J.C.Y., Yap, G.C., et al. Allergy. First published: 02 November 2022
Diagnostic accuracy of vaccine and vaccine excpient testing in the setting of allergic reactions to covid-19 vaccines: a systematic review and meta-analysis
Greenhawt, M., Shaker, M., Golden, D.B.K., et al. Allergy. First published: 02 November 2022
In children with eczema, expansion of epitope-specific IgE is associated with peanut allergy at 5 years of age
Suprun, M., Bahnson, H.T., du Toit, G., et al. Allergy. First published: 02 November 2022
Legends of allergy and immunology: Sergio Romagnani
Maggi, E., Parronchi, P. and Annunziato, F. Allergy. First published: 01 November 2022
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation
Benito-Villalvilla, C., de la Rocha-Muñoz, A., López-Abente, J., et al. Allergy. First published: 31 October 2022
Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation – a 24-year follow up
Tedner, S.G., Klevebro, S., Bergström, A., Kull, et al. Allergy. First published: 31 October 2022
Dysregulated lipidome of sebum in patients with atopic dermatitis
Yin, H., Qiu, Z., Zhu, R., et al. Allergy. First published: 29 October 2022
Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm
Caminati, M., Feleszko, W., Michel, M., Annesi-Maesano, I., Vitte, J. Allergy. First published: 28 October 2022
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”
Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy. First published: 28 October 2022
Potential of biologics to alter the need for repeated surgery in patients with chronic rhinosinusitis with nasal polyps
Xian, M. and Zhang, L. Allergy. First published: 27 October 2022
Biomarkers of asthma relapse and lung function decline in adults with spontaneous asthma remission: a population-based cohort study
Tan, D.J., Lodge, C.J., Walters, E.H., et al. Allergy. First published: 27 October 2022
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study
Akenroye, A., Zhou, G., Jackson, J.W., et al. Allergy. First published: 26 October 2022
Strong association of mast cells with eosinophilic esophagitis-specific signat
Alvarado, D., Lu, Y., Shoda, T., Caldwell, J.M., Keler, T. and Rothenberg, M.E. Allergy. First published: 24 October 2022
Fibrostenotic Eosinophilic Esophagitis phenotype is defined by a proliferative gene signature
Menard-Katcher, C., Liu, C., Galbraith, M.D., et al. Allergy. First published: 22 October 2022
Frequency of food allergy in Europe: an updated systematic review and meta-analysis
Spolidoro, G.C.I., Tesfaye Amera, Y., Ali, M.M., et al. Allergy. First published: 22 October 2022
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Renert-Yuval, Y., Pavel, A.B., Del Duca, E., et al. Allergy. First published: 22 October 2022
Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial
Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022
Prodromes predict attacks of hereditary angioedema: Results of a prospective study
Leibovich-Nassi, I., Golander, H. and Reshef, A. Allergy. First published: 19 October 2022
COP27 Climate Change Conference: Urgent action needed for Africa and the world
Atwoli, L., Erhabor, G.E., Gbakima, A.A., et al. Allergy. First published: 18 October 2022
Furan fatty acid metabolite in newborns predicts risk of asthma
Gürdeniz, G., Kim, M., Brustad, N., et al. Allergy. First published: 17 October 2022
Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases
Walsemann, T., Böttger, M., Traidl, S., et al. Allergy. First published: 14 October 2022
Patient-reported outcome measures (PROMs) in birch pollen allergic patients treated with sublingual immunotherapy reflect real life
Bahbah, F., Gentil, C., Sousa-Pinto, B., et al. Allergy. First published: 13 October 2022
Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response, and asthma control in preschool children with asthma
Gao, Y.-d., Xepapadaki, P., Cui, Y.-w., et al. Allergy. First published: 13 October 2022
Sex hormones and asthma: the role of estrogen in asthma development and severity
Radzikowska, U. and Golebski, K. Allergy. First published: 10 October 2022
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice
Poli, A, Oudin, A, Muller, A, et al. Allergy. First published: 09 October 2022
12-HETE promotes late-phase responses in a murine model of allergic rhinitis
Nakamura, T., Tachibana, Y. and Murata, T. Allergy. First published: 08 October 2022
Dual activation of estrogen receptor alpha and glucocorticoid receptor upregulate CRTh2-mediated type 2 inflammation; mechanism driving asthma severity in women?
Vijeyakumaran, M, Jawhri, MA, Fortunato, J, et al. Allergy. First published: 07 October 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes
Valent, P, Klion, AD, Roufosse, F, et al. Allergy. First published: 07 October 2022
Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo
Goretzki, A., Lin, Y.-J., Meier, C., et al. Allergy. First published: 04 October 2022
Efficacy and safety of food allergy oral immunotherapy in adults
Epstein-Rigbi, N., Levy, M.B., Nachshon, L., et al. Allergy. First published: 03 October 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses
Robb, CT, Zhou, Y, Felton, JM, et al. Allergy. First published: 01 October 2022
Egg and milk exposure during pregnancy and food reactions in grandchildren
Mogensen, I., Flodström, C., Nopp, A., Melén, E., Bergström, A. and Kull, I. Allergy. First published: 30 September 2022
Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis
Okada, N., Yazu, H., Shimizu, E., et al. Allergy. First published: 30 September 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases
Pavel, A.B., Del Duca, E., Cheng, J., et al. Allergy. First published: 30 September 2022
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies – an EAACI Position paper
Vazquez-Ortiz, M., Gore, C., Alviani, C., Angier, et al. Allergy. First published: 29 September 2022
Maternal heated tobacco product use during pregnancy and allergy in offspring
Zaitsu, M., Kono, K., Hosokawa, Y., et al. Allergy. First published: 29 September 2022
Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?
Yasuma, T., D’Alessandro-Gabazza, C.N., Fujimoto, H., et al. Allergy. First published: 28 September 2022
Reply to correspondence: “Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?”
Lee, H., Cho, S.I., Yang, M.-S., Cho, S.-J. and Lee, D.H. Allergy. First published: 28 September 2022
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis
Soyka, M.B., Ryser, F.S., Brühlmann, C., et al. Allergy. First published: 26 September 2022
Citations: 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 474
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 272
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 255
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Citations: 242
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 192
TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation
Toki, S, Goleniewska, K, Zhang, J, et al. Allergy. 2020; 75: 1606– 1617
Citations: 175
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 117
Type 2 immunity in the skin and lungs
Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605
Citations: 97
The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma
Eguiluz-Gracia, I, Mathioudakis, AG, Bartel, S, et al. Allergy. 2020; 75: 2170– 2184
Citations: 92
Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper
Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315
Citations: 90
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma
Agache, I, Song, Y, Posso, M, et al. Allergy. 2021; 76: 45– 58
Citations: 89
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 88
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status
Du, H, Dong, X, Zhang, J-J, et al. Allergy. 2021; 76: 510– 532
Citations: 83
Is asthma protective against COVID-19?
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy.2021; 76: 866-868
Citations: 81
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 81
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
Kwasniewski, M., Korotko, U., Chwialkowska, K., et al. Allergy. First published: 21 September 2022
Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
August 2022 - COVID vaccines and new variants: the light at the end of the tunnel
Volume 77 | Issue 8
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Junior Members,
ISMA-RHINA Digital 2022
The International Symposium on Molecular Allergology (ISMA) and the European Rhinallergy Meeting (RHINA) was held online on 4-5 November 2022.
We had the opportunity to learn about the latest findings in molecular allergology and rhinallergy from internationally renowned experts. A wide variety of topics were presented in different sessions, from plenary and symposium to flash talks and interactive workshop sessions, all accompanied by interesting and exciting live discussions.
During the meeting, the news of the EAACI Molecular Allergology User Guide (MAUG 2.0) were presented, and a wide range of topics on molecular diagnosis, the structure of determinants, chemical modifications of allergens, as well as the latest news on the most relevant advances in airway diseases, immunomodulation and how to transfer these advances from the bench to the clinical routine have been discussed.
The meeting was a resounding success with more than 300 participants learning about new findings to be implemented in both the clinical practice and research labs!
We look forward to seeing you at the next EAACI events!
Best regards,
The Junior Member Assembly
